Stomatitis: Clinical Trials

33 trials for Stomatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed. 33 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 333Completed 33
Phase 26Completed 6

Follow Stomatitis: new trials by email Literature Review of Stomatitis trials Research Report on Stomatitis

Trials (filtered) newest first · largest first

All 33 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis
glutamine combined with thalidomide, glutamine alone - Mucositis Oral
Phase 3CompletedAir Force Military Medical University, China1382023-09-152026-07-01
Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer
Anti-inflammatory/Antimicrobial/Analgesic Aqueous Mouth Rinse, Methylene Blue Oral Rinse - Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Phase 3CompletedMayo Clinic492023-06-062025-04-30
NATIENS: Optimal Management and Mechanisms of SJS/TEN
Harmonized supportive care, Etanercept 50 mg sc day 1 and day 4 - Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses
Phase 3CompletedVanderbilt University Medical Center22023-03-212025-12-17
A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis
MEBO Wound Ointment (MEBO), Tantum Verde® mouthwash - Oral Mucositis (Ulcerative) Due to Radiation
Phase 3CompletedCairo University362023-03-012025-09-22
Omega-3 Hydrogel and Prevention of Oral Mucositis
topical oral Omega-3 hydrogel, conventional preventive treatment - Mucositis Oral
Phase 2 / Phase 3CompletedBasma Morsy362022-02-092023-01-31
Compound Staphylococcal Lysostaphin Vs. Chlorhexidine Mouthrinse for Oral Mucositis in Patients Undergoing Allo-HSCT
compound Staphylococcal lysostaphin mouthrinse, chlorhexidine mouthrinse - Stem Cell Transplant Complications, Oral Mucositis
Phase 3CompletedZhejiang University3882020-01-022025-01-24
Topical Hyaluronic Acid and Recurrent Aphthous Stomatitis.
Hyaluronic acid in the form of hyaluronan sodium 25 mg/100 ml as a mouthwash - Recurrent Aphthous Stomatitis
Phase 3CompletedCairo University342019-11-012020-02-11
Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation.
Selenium, Placebos - Mucositis Oral, Stem Cell Transplant Complications
Phase 3CompletedUniversity Hospital, Angers1002019-10-102024-12-30
ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients
GC4419 90mg, Placebo - Oral Mucositis
Phase 3CompletedGalera Therapeutics, Inc.4552018-10-032023-10-24
Effect of Probiotic Use Bifidobacterium Animalis Subsp. Lactis in Peri-implant Mucositis
Mechanical debridements, Bifidobacterium animalis subsp. lactis - Mucositis Oral
Phase 3CompletedUniversity of Sao Paulo382018-07-012019-12-05
Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
Cisplatin, Intensity Modulated Radiation Therapy, Ulinastatin - Oral Mucositis (Ulcerative) Due to Radiation
Phase 3CompletedSun Yat-sen University1792018-01-302026-05-07
DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
SGX942, Placebo - Squamous Cell Carcinoma of the Oral Cavity and Oropharynx, Oral Mucositis
Phase 3CompletedSoligenix2662017-12-042022-11-08
Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers
Ascorbic Acid, Zinc acetate - Oral Mucositis
Phase 2 / Phase 3CompletedPanineeya Mahavidyalaya Institute of Dental Sciences & Research Centre1802016-08-012019-03-20
Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic
Propolis, Miconazole - Candidiasis, Oral, Stomatitis, Denture
Phase 3CompletedUniversity of Sao Paulo402016-01-012016-06-30
Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment
Anthocyanin, Placebo - Inflammation of Mouth, Acute Mucous Inflammation
Phase 2 / Phase 3CompletedKhon Kaen University702015-08-012017-08-02
Oral Mucositis and Laser Therapy Associated With Photodynamic Therapy
PDT + Low level laser, Low level laser - Oral Mucositis
Phase 3CompletedUniversidade Ceuma182014-10-012015-09-21
Laser for Oral Mucositis in Pediatric Onco-hematology
Laser therapy, Sham therapy - Stomatitis
Phase 3CompletedIRCCS Burlo Garofolo1012013-09-012016-05-04
Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
Intravenous immunoglobulin - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis
Phase 3CompletedNihon Pharmaceutical Co., Ltd102012-10-012014-07-02
Caphosol in Oral Mucositis Due to Targeted Therapy
supersaturated calcium-phosphate, sodium chloride 0.9 % - Oral Complaints, Renal Cell Carcinoma
Phase 3CompletedImpaqtt Foundation642011-11-012017-11-13
Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer
2% morphine solution, Magnesium aluminum hydroxide, 2% viscous lidocaine - Stomatitis
Phase 2 / Phase 3CompletedIsfahan University of Medical Sciences302011-07-012013-04-23

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Head and Neck Neoplasms (7)  ·  Neoplasms (6)  ·  Mucositis (4)  ·  Carcinoma, Squamous Cell (3)  ·  Stevens-Johnson Syndrome (3)  ·  Candidiasis, Oral (2)  ·  Oral Ulcer (2)  ·  Pain (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Stomatitis, Aphthous (2)  ·  Ulcer (2)  ·  Avitaminosis (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Renal Cell (1)

Broader conditions

Mouth Diseases (33)  ·  Stomatognathic Diseases (33)  ·  Neoplasms by Site (9)  ·  Neoplasms by Histologic Type (7)  ·  Digestive System Diseases (6)  ·  Neoplasms (6)  ·  Neoplasms, Glandular and Epithelial (6)  ·  Carcinoma (5)  ·  Gastrointestinal Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Gastroenteritis (4)  ·  Immune System Diseases (4)  ·  Chemically-Induced Disorders (3)  ·  Dermatitis (3)

Interventions

Fibroblast Growth Factor 7 (5)  ·  Low-Level Light Therapy (2)  ·  1-phenyl-3,3-dimethyltriazene (1)  ·  Anthocyanins (1)  ·  Anti-Inflammatory Agents (1)  ·  Ascorbic Acid (1)  ·  Benzydamine (1)  ·  Cisplatin (1)  ·  Diphenhydramine (1)  ·  Etanercept (1)  ·  Geritol (1)  ·  Glutamine (1)  ·  Hyaluronic Acid (1)  ·  Immunoglobulins, Intravenous (1)  ·  Injections (1)

Sponsors

Amgen (3)  ·  Cairo University (2)  ·  Swedish Orphan Biovitrum (2)  ·  University of Sao Paulo (2)  ·  Air Force Military Medical University, China (1)  ·  Basma Morsy (1)  ·  Biotec Pharmacon ASA (1)  ·  Galera Therapeutics, Inc. (1)  ·  IRCCS Burlo Garofolo (1)  ·  Impaqtt Foundation (1)  ·  Instituto Nacional de Cancer, Brazil (1)  ·  Isfahan University of Medical Sciences (1)  ·  Khon Kaen University (1)  ·  Marilyn Dodd (1)  ·  Mayo Clinic (1)

Countries

United States (7)  ·  Brazil (4)  ·  China (3)  ·  Egypt (3)  ·  France (3)  ·  Canada (2)  ·  Belgium (1)  ·  Germany (1)  ·  India (1)  ·  Iran (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Puerto Rico (1)  ·  Singapore (1)

Top investigators

Brian M Feldman, MD, MSc (1)  ·  Carlos G Ferreira, MD, PhD (1)  ·  Christine B. Boers-Doets, MSc (1)  ·  Dietger Niederwieser, Professor (1)  ·  Donald T Tan, FRCS (1)  ·  Elizabeth J Phillips, MD (1)  ·  Erica N Lia, PhD (1)  ·  Gene Kennedy, MD (1)  ·  Gisela M Pina, DDS (1)  ·  Giulio Andrea Zanazzo, MD (1)  ·  Hans Gelderblom, MD, PhD (1)  ·  Heliton S Antunes, DDS, PhD (1)  ·  Kristina Timdahl, MD (1)  ·  Leonard P Ang, FRCS (1)

Results publications

PMID 10423050, PMID 15161841, PMID 15287367, PMID 15602019, PMID 16161031, PMID 16391299, PMID 16415901, PMID 16862549, PMID 17580258, PMID 18413833, PMID 18696746, PMID 18754720, PMID 19125084, PMID 19733615, PMID 20141576, PMID 21394411, PMID 21473845, PMID 21537592, PMID 21911312, PMID 22057503, PMID 22077475, PMID 22467697, PMID 24119379, PMID 25161649, PMID 25198431, PMID 26559740, PMID 26916845, PMID 31618127, PMID 34145168, PMID 35634695, PMID 41127563

NIH funding

2018 (1), R01CA107080 (1)